Intrinsiqq
Aprea Therapeutics, Inc. logo

Aprea Therapeutics, Inc. Insider Trading

APRE

Compare
Last 12 months

Insiders bought 61K on the open market and sold nothing.

Net open-market
+61K
4 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
3 / 0
executives and directors
Last open-market buy
Jan 2026
Jan 30, 2026

Get an email when APRE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jan 30
    Oren Gilad
    President/CEO · bought 28,100 at $0.89
    25K
    8.1% of stake
  • Jan 30
    John P. Hamill
    SrVP/CFO/Prin Fin & Acct Ofcr · bought 5,700 at $0.89
    5K
    21% of stake
  • Dec 10, 2025
    Marc Duey
    Director · bought 21,459 at $1.17
    25K
    9.1% of stake
  • Dec 10, 2025
    John P. Hamill
    SrVP/CFO/Prin Fin & Acct Ofcr · bought 5,000 at $1.17
    6K
    22% of stake
  • Apr 3, 2025
    Oren Gilad
    President/CEO · bought 5,500 at avg $1.84
    10K
    1.6% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch APRE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with APRE

CompareIntrinsic value
CLNNClene Inc.
$3.44-1.86%15
ZOMDFZomedica Corp.
$0.08-3.49%46
SMNRSemnur Pharmaceuticals, Inc.
$0.15-40.00%0
NATRNature's Sunshine Products Inc.
$10.19+0.20%68
LFCRLifecore Biomedical, Inc.
$6.39+0.31%21
QTTBQ32 Bio Inc.
$8.34-1.65%60
LYELLyell Immunopharma, Inc.
$13.80+1.62%10
OPKOpko Health Inc.
$1.57-2.48%28

Spot a number that looks wrong? Check it in APRE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing APRE

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.